As of 4:00pm ET
| -0.02 / -0.37%|
The 6 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 11.50, with a high estimate of 15.00 and a low estimate of 7.00. The median estimate represents a +113.36% increase from the last price of 5.39.
The current consensus among 6 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.